{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:31:55Z","timestamp":1785929515915,"version":"3.56.0"},"publisher-location":"New York, NY","reference-count":42,"publisher":"Springer US","isbn-type":[{"value":"9781071647219","type":"print"},{"value":"9781071647226","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4722-6_9","type":"book-chapter","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T21:28:25Z","timestamp":1754083705000},"page":"145-154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["NMR-Based Quantification of GlycA and GlycB: Advancing Inflammatory Biomarkers in Clinical Diagnostics"],"prefix":"10.1007","author":[{"given":"Nieves","family":"Embade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev.biochem.66.1.315","volume":"66","author":"GW Hart","year":"1997","unstructured":"Hart GW (1997) Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem 66:315\u2013335","journal-title":"Annu Rev Biochem"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1021\/bp0704034","volume":"24","author":"PK Qasba","year":"2008","unstructured":"Qasba PK, Boeggeman E, Ramakrishnan B (2008) Site-specific linking of biomolecules via glycan residues using glycosyltransferases. Biotechnol Prog 24:520\u2013526","journal-title":"Biotechnol Prog"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nchembio.1403","volume":"9","author":"MA Wolfert","year":"2013","unstructured":"Wolfert MA, Boons GJ (2013) Adaptive immune activation: glycosylation does matter. Nat Chem Biol 9:776\u2013784","journal-title":"Nat Chem Biol"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-024-01886-1","volume":"9","author":"M He","year":"2024","unstructured":"He M, Zhou X, Wang X (2024) Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduct Target Ther 9:9. https:\/\/doi.org\/10.1038\/s41392-024-01886-1","journal-title":"Signal Transduct Target Ther"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1155\/2008\/493289","volume":"25","author":"O Gornik","year":"2008","unstructured":"Gornik O, Lauc G (2008) Glycosylation of serum proteins in inflammatory diseases. Dis Markers 25:267\u2013278","journal-title":"Dis Markers"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/nri2417","volume":"8","author":"JD Marth","year":"2008","unstructured":"Marth JD, Grewal PK (2008) Mammalian glycosylation in immunity. Nat Rev Immunol 8:874\u2013887","journal-title":"Nat Rev Immunol"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1021\/pr500146y","volume":"13","author":"C McCarthy","year":"2014","unstructured":"McCarthy C, Saldova R, Wormald MR, Rudd PM, McElvaney NG, Reeves EP (2014) The role and importance of glycosylation of acute phase proteins with focus on alpha-1 antitrypsin in acute and chronic inflammatory conditions. J Proteome Res 13:3131\u20133143","journal-title":"J Proteome Res"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnins.2020.625348","volume":"14","author":"H Haukedal","year":"2021","unstructured":"Haukedal H, Freude KK (2021) Implications of glycosylation in Alzheimer\u2019s disease. Front Neurosci 14:14. https:\/\/doi.org\/10.3389\/fnins.2020.625348","journal-title":"Front Neurosci"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1373\/clinchem.2014.232918","volume":"61","author":"JD Otvos","year":"2015","unstructured":"Otvos JD, Shalaurova I, Wolak-Dinsmore J et al (2015) GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation. Clin Chem 61:714\u2013723","journal-title":"Clin Chem"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1371\/journal.pone.0139057","volume":"10","author":"EG Gruppen","year":"2015","unstructured":"Gruppen EG, Riphagen IJ, Connelly MA, Otvos JD, Bakker SJL, Dullaart RPF (2015) GlycA, a pro-inflammatory glycoprotein biomarker, and incident cardiovascular disease: relationship with C-reactive protein and renal function. PLoS One 10:10. https:\/\/doi.org\/10.1371\/journal.pone.0139057","journal-title":"PLoS One"},{"key":"9_CR11","doi-asserted-by":"crossref","unstructured":"Abay EG (1999) Mechanisms of disease A cute-phase proteins and other systemic responses to inflammation. N Engl J Med","DOI":"10.1056\/NEJM199902113400607"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12967-017-1321-6","volume":"15","author":"MA Connelly","year":"2017","unstructured":"Connelly MA, Otvos JD, Shalaurova I, Playford MP, Mehta NN (2017) GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. J Transl Med 15:15. https:\/\/doi.org\/10.1186\/s12967-017-1321-6","journal-title":"J Transl Med"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9082472","volume":"9","author":"J Rodr\u00edguez-Carrio","year":"2020","unstructured":"Rodr\u00edguez-Carrio J, Alperi-L\u00f3pez M, L\u00f3pez P et al (2020) Glyca levels during the earliest stages of rheumatoid arthritis: potential use as a biomarker of subclinical cardiovascular disease. J Clin Med 9:1\u201319","journal-title":"J Clin Med"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajpc.2020.100120","volume":"4","author":"NN Mehta","year":"2020","unstructured":"Mehta NN, Dey AK, Maddineni R, Kraus WE, Huffman KM (2020) GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases. Am J Prev Cardiol 4:4. https:\/\/doi.org\/10.1016\/j.ajpc.2020.100120","journal-title":"Am J Prev Cardiol"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/ecco-jcc\/jjy162","volume":"13","author":"T Dierckx","year":"2019","unstructured":"Dierckx T, Verstockt B, Vermeire S, Van Weyenbergh J (2019) Glyca, a nuclear magnetic resonance spectroscopy measure for protein glycosylation, is a viable biomarker for disease activity in ibd. J Crohns Colitis 13:389\u2013394","journal-title":"J Crohns Colitis"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.bbcan.2020.188464","volume":"1875","author":"D Thomas","year":"2021","unstructured":"Thomas D, Rathinavel AK, Radhakrishnan P (2021) Altered glycosylation in cancer: a promising target for biomarkers and therapeutics. Biochim Biophys Acta Rev Cancer 1875:1875. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188464","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fmolb.2023.1158330","volume":"10","author":"G Bae","year":"2023","unstructured":"Bae G, Berezhnoy G, Koch A et al (2023) Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers. Front Mol Biosci 10:10. https:\/\/doi.org\/10.3389\/fmolb.2023.1158330","journal-title":"Front Mol Biosci"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21037\/jlpm.2020.03.03","volume":"5","author":"RA Ballout","year":"2020","unstructured":"Ballout RA, Remaley AT (2020) GlycA: a new biomarker for systemic inflammation and cardiovascular disease (CVD) risk assessment. J Lab Precis Med 5:17\u201317","journal-title":"J Lab Precis Med"},{"key":"9_CR19","first-page":"152","volume":"20","author":"L An","year":"2018","unstructured":"An L, Liu Q, Feng H et al (2018) Increased glycoprotein acetylation is associated with high cardiac event rates: analysis using coronary computed tomography angiography. Anatol J Cardiol 20:152\u2013158","journal-title":"Anatol J Cardiol"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.numecd.2021.03.021","volume":"31","author":"T Ser\u00e9s-Noriega","year":"2021","unstructured":"Ser\u00e9s-Noriega T, Gim\u00e9nez M, Perea V et al (2021) Quantification of glycoproteins by nuclear magnetic resonance associated with preclinical carotid atherosclerosis in patients with type 1 diabetes. Nutr Metab Cardiovasc Dis 31:2099\u20132108","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-024-02363-3","volume":"23","author":"R Gil-Redondo","year":"2024","unstructured":"Gil-Redondo R, Conde R, Bruzzone C et al (2024) MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics. Cardiovasc Diabetol 23:23. https:\/\/doi.org\/10.1186\/s12933-024-02363-3","journal-title":"Cardiovasc Diabetol"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jacl.2020.07.012","volume":"14","author":"JA Levine","year":"2020","unstructured":"Levine JA, Han JM, Wolska A et al (2020) Associations of GlycA and high-sensitivity C-reactive protein with measures of lipolysis in adults with obesity. J Clin Lipidol 14:667\u2013674","journal-title":"J Clin Lipidol"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fendo.2021.775677","volume":"12","author":"J Moreno-Vedia","year":"2022","unstructured":"Moreno-Vedia J, Rosales R, Ozcariz E et al (2022) Triglyceride-rich lipoproteins and glycoprotein a and B assessed by 1H-NMR in metabolic-associated fatty liver disease. Front Endocrinol (Lausanne) 12:12. https:\/\/doi.org\/10.3389\/fendo.2021.775677","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9_CR24","doi-asserted-by":"publisher","unstructured":"Fung E, Chan EYS, Ng KH, Yu KM, Li H, Wang Y (2023) Towards clinical application of GlycA and GlycB for early detection of inflammation associated with (pre)diabetes and cardiovascular disease: recent evidence and updates. J Inflam (UK) 20. https:\/\/doi.org\/10.1186\/s12950-023-00358-7","DOI":"10.1186\/s12950-023-00358-7"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41398-023-02446-x","volume":"13","author":"P Pradeep","year":"2023","unstructured":"Pradeep P, Kang H, Lee B (2023) Glycosylation and behavioral symptoms in neurological disorders. Transl. Psychiatry 13:13. https:\/\/doi.org\/10.1038\/s41398-023-02446-x","journal-title":"Psychiatry"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41598-024-67177-5","volume":"14","author":"N Liang","year":"2024","unstructured":"Liang N, Nho K, Newman JW et al (2024) Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer\u2019s disease. Sci Rep 14:14. https:\/\/doi.org\/10.1038\/s41598-024-67177-5","journal-title":"Sci Rep"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1021\/acs.jproteome.2c00847","volume":"22","author":"X Gallart-Palau","year":"2023","unstructured":"Gallart-Palau X, Muntan\u00e9 G, Martorell L et al (2023) Gradual increase in inflammation-linked glycoproteins and a proatherogenic lipoprotein profile in the early stages of psychosis as characterized by 1H NMR blood analysis. J Proteome Res 22:2271\u20132280","journal-title":"J Proteome Res"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fmolb.2023.1111482","volume":"10","author":"C Bruzzone","year":"2023","unstructured":"Bruzzone C, Conde R, Embade N, Mato JM, Millet O (2023) Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19. Front Mol Biosci 10:10. https:\/\/doi.org\/10.3389\/fmolb.2023.1111482","journal-title":"Front Mol Biosci"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1021\/acs.jproteome.0c00876","volume":"20","author":"S Lodge","year":"2021","unstructured":"Lodge S, Nitschke P, Kimhofer T et al (2021) NMR spectroscopic windows on the systemic effects of SARS-CoV-2 infection on plasma lipoproteins and metabolites in relation to circulating cytokines. J Proteome Res 20:1382\u20131396","journal-title":"J Proteome Res"},{"key":"9_CR30","doi-asserted-by":"crossref","unstructured":"Kimhofer T, Lodge S, Whiley L, et al. Integrative modeling of quantitative plasma lipoprotein, metabolic,and amino acid data reveals a multiorgan pathological signature of SARS-CoV-2. J Proteome Res 2020, 19, 4442","DOI":"10.1021\/acs.jproteome.0c00519"},{"key":"9_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101645","volume":"23","author":"C Bruzzone","year":"2020","unstructured":"Bruzzone C, Bizkarguenaga M, Gil-Redondo R et al (2020) SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum. iScience 23:101645","journal-title":"iScience"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s43856-023-00365-y","volume":"3","author":"J Kazenwadel","year":"2023","unstructured":"Kazenwadel J, Berezhnoy G, Cannet C et al (2023) Stratification of hypertension and SARS-CoV-2 infection by quantitative NMR spectroscopy of human blood serum. Commun Med 3:145","journal-title":"Commun Med"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1021\/acs.jproteome.3c00803","volume":"23","author":"S Lodge","year":"2024","unstructured":"Lodge S, Litton E, Gray N et al (2024) Stratification of sepsis patients on admission into the intensive care unit according to differential plasma metabolic phenotypes. J Proteome Res 23:1328\u20131340","journal-title":"J Proteome Res"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1021\/acs.analchem.1c05389","volume":"94","author":"R Masuda","year":"2022","unstructured":"Masuda R, Lodge S, Whiley L et al (2022) Exploration of human serum lipoprotein supramolecular phospholipids using statistical heterospectroscopy in n -dimensions (SHY- n): identification of potential cardiovascular risk biomarkers related to SARS-CoV-2 infection. Anal Chem 94:4426\u20134436","journal-title":"Anal Chem"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/metabo12121277","volume":"12","author":"T R\u00f6ssler","year":"2022","unstructured":"R\u00f6ssler T, Berezhnoy G, Singh Y et al (2022) Quantitative serum NMR spectroscopy stratifies COVID-19 patients and sheds light on interfaces of host metabolism and the immune response with cytokines and clinical parameters. Meta 12:12. https:\/\/doi.org\/10.3390\/metabo12121277","journal-title":"Meta"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/metabo12121206","volume":"12","author":"R Gil-Redondo","year":"2022","unstructured":"Gil-Redondo R, Conde R, Bizkarguenaga M et al (2022) An NMR-based model to investigate the metabolic Phenoreversion of COVID-19 patients throughout a longitudinal study. Meta 12:12. https:\/\/doi.org\/10.3390\/metabo12121206","journal-title":"Meta"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.sbi.2020.09.009","volume":"68","author":"L Unione","year":"2021","unstructured":"Unione L, Ard\u00e1 A, Jim\u00e9nez-Barbero J, Millet O (2021) NMR of glycoproteins: profiling, structure, conformation and interactions. Curr Opin Struct Biol 68:9\u201317","journal-title":"Curr Opin Struct Biol"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/QAD.0000000000003094","volume":"36","author":"AM Anderson","year":"2022","unstructured":"Anderson AM, Bhondoekhan F, Curanovic D et al (2022) GlycA is associated with neuropsychological impairment in men with HIV. AIDS 36:156\u2013159","journal-title":"AIDS"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/life11121407","volume":"11","author":"N Amig\u00f3","year":"2021","unstructured":"Amig\u00f3 N, Fuertes-Mart\u00edn R, Malo AI et al (2021) Glycoprotein profile measured by a1 H-nuclear magnetic resonance based on approach in patients with diabetes: a new robust method to assess inflammation. Life 11:11. https:\/\/doi.org\/10.3390\/life11121407","journal-title":"Life"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1021\/acs.jproteome.8b00411","volume":"17","author":"R Fuertes-Mart\u00edn","year":"2018","unstructured":"Fuertes-Mart\u00edn R, Taverner D, Vallv\u00e9 JC et al (2018) Characterization of 1H NMR plasma glycoproteins as a new strategy to identify inflammatory patterns in rheumatoid arthritis. J Proteome Res 17:3730\u20133739","journal-title":"J Proteome Res"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1021\/acs.analchem.1c04576","volume":"94","author":"P Nitschke","year":"2022","unstructured":"Nitschke P, Lodge S, Kimhofer T et al (2022) J-edited diffusional proton nuclear magnetic resonance spectroscopic measurement of glycoprotein and supramolecular phospholipid biomarkers of inflammation in human serum. Anal Chem 94:1333\u20131341","journal-title":"Anal Chem"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/anie.202306154","volume":"62","author":"A Mallagaray","year":"2023","unstructured":"Mallagaray A, Rudolph L, Lindloge M et al (2023) Towards a precise NMR quantification of acute phase inflammation proteins from human serum. Angewandte Chemie\u2014International Edition 62:62. https:\/\/doi.org\/10.1002\/anie.202306154","journal-title":"Angewandte Chemie\u2014International Edition"}],"container-title":["Methods in Molecular Biology","NMR of Glycoproteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4722-6_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:35:31Z","timestamp":1780911331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4722-6_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647219","9781071647226"],"references-count":42,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4722-6_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"2 August 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}